enGene Therapeutics (ENGN) Accounts Payables (2022 - 2026)
enGene Therapeutics' Accounts Payables was $2.54 million in fiscal Q3 2026 (quarter ended Jul 31, 2026), up 6.6% from $2.38 million a year earlier and up 41.7% from the prior quarter.
Powered by 
Analysis
enGene Therapeutics (ENGN) Accounts Payables (2022 - 2026) Analysis & Trends
At the end of FY2025 (ended Oct 31, 2025), Accounts Payables at enGene Therapeutics came in at $6.69 million, up 374.0% from FY2024.
- Accounts Payables has now increased for three consecutive fiscal years, with a three-year compound annual growth rate of 109.9% (FY2022 to FY2025).
- In earlier fiscal years, Accounts Payables was $1.41 million in FY2024 (+22.1%), $1.16 million in FY2023 (+59.9%) and $723,000 in FY2022.
- Quarterly Accounts Payables has moved between $211,000 (fiscal Q2 2024) and $6.69 million (fiscal Q4 2025) over five years.
- Compared with a year earlier, Accounts Payables was higher in six of the last eight quarters, with growth averaging 142.6%.
- The best year-over-year quarter for Accounts Payables over five years was fiscal Q2 2025 (growth of 642.7%); the worst was fiscal Q3 2025 (a decline of 16.7%).
- Per Business Quant data, ENGN's Accounts Payables in the three fiscal quarters before Q3 2026 was $1.79 million (Q2 2026), $2.44 million (Q1 2026) and $6.69 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 9.32 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 5.03 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | -23.57 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 4.07 Bn |
| 10 | enGene Therapeutics | 161.50 Mn | -832.97 Mn | - | 2.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 2.54 Mn |
| Apr 30, 2026 | 1.79 Mn |
| Jan 31, 2026 | 2.44 Mn |
| Oct 31, 2025 | 6.69 Mn |
| Jul 31, 2025 | 2.38 Mn |
| Apr 30, 2025 | 1.57 Mn |
| Jan 31, 2025 | 2.61 Mn |
| Oct 31, 2024 | 1.41 Mn |
| Jul 31, 2024 | 2.86 Mn |
| Apr 30, 2024 | 211,000.00 |
| Jan 31, 2024 | 1.28 Mn |
| Oct 31, 2023 | 1.16 Mn |
| Oct 31, 2022 | 723,000.00 |
API Access
enGene Therapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();